TransMedics Group (TMDX) executive compensation, 2026 proxy

Waleed H. Hassanein, M.D., President and Chief Executive Officer, was paid $10.9M in 2025, up 33% from $8.2M the year before. The CEO-to-median-employee pay ratio was 86:1, on median employee pay of $127,304.

Filed
April 10, 2026
Annual meeting
May 20, 2026
Pay year
2025
Named executives
5
CEO total pay
$10.9M+33% vs prior year
CEO to median employee
86:1median $127,304
CEO pay in equity
80%$8.7M in awards
Prior say-on-pay support
97%of votes cast
CEO Target Bonus
$800,000Target annual cash bonus opportunity
CEO Maximum Bonus
$1,600,000Maximum annual cash bonus opportunity
Total Revenue Growth
37%Year-over-year growth to $605.5 million
Operating Margins
18%Expanded from 8.5% in 2024

How M.D. was paid

$10.9M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary7%Stock awards40%Option awards40%Non-equity incentive13%All other compensation0%

Named executive officers

ExecutiveTotal
Waleed H. Hassanein, M.D.President and Chief Executive Officer$10,915,533
Gerardo HernandezChief Financial Officer$1,570,572
Tamer Khayal, M.D.Former Chief Commercial Officer$3,750,144
Nicholas CorcoranSenior Vice President of Supply Chain and Operations$2,819,576
Anil RanganathFormer Senior Vice President, General Counsel and Corporate Secretary$1,503,075

What changed and why

  • 33%Waleed H. Hassanein earned a total compensation of $10,915,533 in 2025, representing a 33% increase from 2024.
  • 50%Long-term incentives were granted using an equal mix of 50% stock options and 50% RSUs.
  • Annual cash bonuses for executive officers were driven by a formulaic measurement of revenue.
  • The ratio of the CEO's annual total compensation to the median employee total compensation was 86 to 1.
  • 96.5%Approximately 96.5% of the shares voted approved the advisory say-on-pay proposal at the 2025 annual meeting.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.